VYJUVEK

FDA Drug Profile — VYJUVEK

VYJUVEK is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including VYJUVEK. Available dosage form: kit.

Drug details

Generic Name
VYJUVEK
Brand Names
VYJUVEK
Application Number
BLA125774
Sponsor
Krystal Biotech, Inc.
NDC Codes
2
Dosage Forms
KIT

Indications and Usage

1 INDICATIONS AND USAGE VYJUVEK is indicated for the treatment of wounds in adult and pediatric patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene. VYJUVEK is a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy indicated for the treatment of wounds in adult and pediatric patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene. (1)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.